Multiple endocrine neoplasia type 2 laboratory findings: Difference between revisions
(Created page with "__NOTOC__ {{}} {{CMG}}; {{AE}} {{Ammu}} ==Overview== ==Laboratory Tests== ===Blood Test=== * Elevated Calcitonin (>=100 pg/mL) * Pentagastrin * Elevated epinephrine * Elevated...") |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{}} | {{Multiple endocrine neoplasia type 2}} | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
==Overview== | ==Overview== | ||
| Line 13: | Line 13: | ||
===Urine Test=== | ===Urine Test=== | ||
* Elevated norepinephrine | * Elevated norepinephrine | ||
* Elevated metanephrine | * Elevated metanephrine | ||
* Elevated vanillylmandelic acid | * Elevated vanillylmandelic acid | ||
Revision as of 19:44, 21 September 2015
|
Multiple endocrine neoplasia type 2 Microchapters |
|
Differentiating Multiple endocrine neoplasia type 2 from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Multiple endocrine neoplasia type 2 laboratory findings On the Web |
|
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 laboratory findings |
|
FDA on Multiple endocrine neoplasia type 2 laboratory findings |
|
CDC on Multiple endocrine neoplasia type 2 laboratory findings |
|
Multiple endocrine neoplasia type 2 laboratory findings in the news |
|
Blogs on Multiple endocrine neoplasia type 2 laboratory findings |
|
Directions to Hospitals Treating Multiple endocrine neoplasia type 2 |
|
Risk calculators and risk factors for Multiple endocrine neoplasia type 2 laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Laboratory Tests
Blood Test
- Elevated Calcitonin (>=100 pg/mL)
- Pentagastrin
- Elevated epinephrine
- Elevated norepinephrine
- Elevated metanephrine
- Elevated vanillylmandelic acid
Urine Test
- Elevated norepinephrine
- Elevated metanephrine
- Elevated vanillylmandelic acid